SciTransfer
environMENTAL · Project

AI-Driven Mental Health Diagnostics and VR Therapy for Environmental Stress

healthTestedTRL 5

Imagine if your phone and satellite data could predict when city noise or heatwaves might trigger a mental health crisis. This work connects huge health records with weather and city maps to find the biological 'tripwires' in our brains. It then uses virtual reality and new medicines to help people stay resilient against these external pressures.

By the numbers
1.5 million
European citizens and patients in cohort data
28
Consortium partners
9
Participating countries
The business problem

What needed solving

Mental health services lack objective biomarkers to predict how environmental stressors like climate change or urbanization will trigger illness in specific individuals.

The solution

What was built

A digital health platform (StreetMind), a genetic analysis tool (FEMA GWAS), and a spatial data infrastructure for environmental mapping.

Audience

Who needs this

Precision medicine pharmaceutical companiesDigital health app developersVR-based mental health clinicsPublic health insurance providers
Business applications

Who can put this to work

Pharmaceuticals
enterprise
Target: Drug discovery firm

If you are a drug discovery firm dealing with a lack of specific targets for environmental depression — this project developed a compound screening process based on molecular mechanisms that identifies new pharmacological targets.

Digital Health
SME
Target: Health app developer

If you are a health app developer dealing with low user engagement and generic tracking — this project developed the StreetMind platform that captures digital biomarkers using neuro-psycho-behavioural stratification.

Healthcare Technology
mid-size
Target: VR therapy provider

If you are a VR therapy provider dealing with a lack of evidence-based content — this project developed VR interventions based on adverse environmental features to reduce symptom progression.

Frequently asked

Quick answers

What is the cost or pricing for the developed tools?

Based on available project data, specific pricing for the tools is not mentioned, though the project received an EU contribution of EUR 9,045,288.

Can this be scaled to an industrial level?

The project leverages data from 1.5 million Europeans and uses federated learning via the COINSTAC platform, suggesting a high capacity for large-scale data processing.

What is the IP and licensing status of the FEMA GWAS tool?

Based on available project data, the project developed the FEMA GWAS tool for genetic data analysis, but specific licensing terms are not provided.

How is the data integrated across different countries?

The project uses a spatial data infrastructure and federated learning to securely analyze data across 9 countries.

What is the timeline for market availability?

The project period runs from 2022-06-01 to 2027-05-31, indicating that final results and validated interventions will be available by May 2027.

Consortium

Who built it

The consortium is heavily research-oriented with 19 universities and 4 research institutes, but maintains a significant industrial presence with 5 companies (18% ratio), including 3 SMEs. This balance suggests that while the core is scientific, there is a built-in pipeline for commercial translation across 9 countries.

How to reach the team

Contact Charité - Universitätsmedizin Berlin

Next steps

Talk to the team behind this work.

Request a deep dive into the FEMA GWAS tool and StreetMind API capabilities.

More in Health & Biomedical
See all Health & Biomedical projects